AdamsonJones, patent and trade mark attorneys, is the latest company to open the doors to its new office at MediCity, a hub for health, beauty and wellness innovation located at the Boots site in Beeston, Nottingham. MediCity is a joint venture between BioCity, one of the UK’s largest innovation centres for biotechnology companies, and Alliance Boots, and is one of the first projects to be completed within the Nottingham Enterprise Zone.
Dr Steve Jones, Director at AdamsonJones, says “Having a presence at MediCity will enable us to work side by side with a growing community of innovative start-ups and young businesses that are developing technologies for consumer healthcare. We will be on hand to lend our advice and expertise in IP to small and medium-sized enterprises as they look to commercialise their innovations and feed them into the health and beauty supply chain.”
Steve explains “AdamsonJones is heavily invested in the industries we serve and having offices at both BioCity and MediCity places us at the heart of innovation in pharmaceuticals and healthcare. Being part of the BioCity community has allowed us to collaborate and share knowledge with many progressive organisations and businesses active in the area of chemistry and life sciences and we hope MediCity will offer similar opportunities.”
AdamsonJones has a longstanding working relationship with Alliance Boots. In particular, Liz Smith, Joint Head of the company’s Chemistry & Life Sciences team, is looking forward to returning to the Boots site.
Liz began her association with Boots in 1985, as a trainee in the patents department at Boots Pharmaceuticals, based at the site now occupied by BioCity. Liz recalls “When Boots Pharmaceuticals was sold to BASF in 1995 the patent department was relocated to the current Boots site at Beeston. By this point most of the work I was doing was in support of Boots Healthcare International (BHI), which was set up in 1990 building on the success of Ibuprofen becoming an ‘over the counter’ drug in the UK and overseas.”
“Boots Healthcare International was based in the D6 building at Beeston, so I spent a significant amount of time over there, as Head of Patents for Boots, undertaking patent work for new Ibuprofen formulations, and filing registered designs on the packaging.” D6 is a Grade One listed Art Deco building, originally designed for the manufacture of ‘dry’ products such as powders, tablets and lozenges, and now home to MediCity.
In 2004 Liz joined AdamsonJones, moving to BioCity, her previous home whilst working at Boots Pharmaceuticals. Liz continued to support BHI’s patent work, often working from D6, until BHI was eventually sold to Reckitt Benckiser in 2009. Liz is now heading back to D6 and will be splitting her time between the new office at MediCity and the company’s head office at BioCity.